Clonazepam Tablets — Class II drug recall D-1087-2014
Terminated recall by Actavis Elizabeth LLC, reported 2014-03-05, distributed nationwide. Subpotent Drug: During routine stability testing one tablet was found with tablet weight below specification.
| Recall number | D-1087-2014 |
|---|---|
| Product type | Drug |
| Classification | Class II |
| Status | Terminated |
| Voluntary or mandated | Voluntary |
| Recalling firm | Actavis Elizabeth LLC, Elizabeth, NJ, United States |
| Recall initiated | 2013-11-06 |
| Classified | 2014-02-21 |
| Reported by FDA | 2014-03-05 |
| Terminated | 2014-06-02 |
| Distributed | Nationwide (US) |
| Quantity | 13,608 bottles |
| Reason classes | potency, specification failure |
| NDC | 00228-3005-11 |
| Lot numbers | 05/15, 58468552 |
Product
Clonazepam Tablets, USP 2 mg 100 tablets Manufactured by: Actavis Elizabeth LLC 200 Elmora Avenue, Elizabeth, NJ 0737 USA NDC 0228-3005-11 packaged in White/Round HDPE 75 CC with white/round plastic 33 mm CRC closure shipped in corrugated 75 cc carton (24 bottles/carton)
Reason for recall
Subpotent Drug: During routine stability testing one tablet was found with tablet weight below specification.
Machine access
This record, with every extracted code, the verbatim FDA record and provenance, is available from the recall API: GET https://api.data.aroqon.com/v1/recalls/D-1087-2014. Look up any UPC, UDI, NDC or lot with /v1/recalls/lookup?code=…. API docs · free and paid keys.
Source: U.S. Food and Drug Administration enforcement report via openFDA (CC0). Structured by Data Foundry (recall-structuring@2); last changed 2026-09-26. Not affiliated with or endorsed by FDA. Not medical or legal advice.